Phosphorylation in several residues contributes to the formation of pathological tau aggregates in the human AD brain, notably at Thr217, Thr181, and Thr231, which have also been demonstrated as biomarkers of AD in tissues and fluids.25, 41, 42, 68. The gene discussed is MAPT; the disease is Alzheimer disease.